Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease

Journal of Clinical Neuroscience

Volumn 18, Issue 8, 2011, Pages 1093-1096

  Kashihara, Kenichi ^a   Shinya, Takayoshi ^a   Higaki, Fumiyo ^a  

^a OKAYAMA KYOKUTO HOSPITAL   (Japan)

Author keywords

Melanin; MRI; Neuromelanin; Parkinson's disease; Pars compacta; Substantia nigra

Indexed keywords

MELANIN; NEUROMELANIN;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN ISCHEMIA; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NERVE CELL DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA PARS COMPACTA ATROPHY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MELANINS; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA;

EID: 79960740078     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.08.043     Document Type: Article

References (24)

1. J.M. Fearnley, and A.J. Lees Aging and Parkinson's disease: substantia nigra regional selectivity Brain 114 1991 2283 2301
2. K. Kosaka, M. Yoshimura, and K. Ikeda Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease? Clin Neuropathol 3 1984 185 192 (Pubitemid 14015451)
3. H. Oikawa, M. Sasaki, and Y. Tamakawa The substantia nigra in Parkinson's disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings Am J Neuroradiol 23 2002 1747 1756 (Pubitemid 35304115)
4. S.J. Huber, D.W. Chakeres, and G.W. Paulson Magnetic resonance imaging in Parkinson's disease Arch Neurol 47 1990 735 737 (Pubitemid 20208611)
5. J. Vymazal, A. Righini, and R.A. Brooks T1 and T2 in the brain of healthy subjects, patients with Parkinson disease and patients with multiple system atrophy: relation to iron content Radiology 211 1999 489 495 (Pubitemid 29206821)
6. A. Antonini, K.L. Leenders, and D. Meier T2 relaxation time in patients with Parkinson's disease Neurology 43 1993 697 700 (Pubitemid 23121959)
7. J.M. Gorell, R.J. Ordidge, and G.G. Brown Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease Neurology 45 1995 1138 1143
8. P. Ryvlin, E. Broussolle, and H. Piollet Magnetic resonance imaging evidence of decreased putaminal iron content in idiopathic Parkinson's disease Arch Neurol 52 1995 583 588
9. G. Bartzokis, J.L. Cummings, and C.H. Markham MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects Magn Reson Imaging 17 1999 213 222 (Pubitemid 29053180)
10. J.M. Graham, M.N. Paley, and R.A. Grünewald Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence Brain 123 2000 2423 2431
11. W.R.W. Martin, M. Wieler, and M. Gee Midbrain iron content in early Parkinson disease. A potential biomarker of disease status Neurology 70 2008 1411 1417 (Pubitemid 351521933)
12. D. Berg In vivo detection of iron and neuromelanin by transcranial sonography - a new approach for early detection of substantia nigra damage J Neural Transm 113 2006 775 780 (Pubitemid 43847171)
13. B. Ravina, D. Eidelberg, and J.E. Ahlskog The role of radiotracer imaging in Parkinson disease Neurology 64 2005 208 215
14. M. Sasaki, E. Shibata, and K. Tohyama Neuromelanin magnetic resonance imaging of the locus ceruleus and substantia nigra in Parkinson's disease Neuroreport 17 2006 1215 1218 (Pubitemid 44051416)
15. M. Sasaki, E. Shibata, and K. Tohyama Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications Neuroreport 19 2008 1649 1654
16. W.R. Gibb, and A.J. Lees The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease Neuropathol Appl Neurobiol 15 1989 27 44 (Pubitemid 19074096)
17. J.C. van Swieten, P.J. Koudstaal, and M.C. Visser Interobserver agreement for the assessment of handicap in stroke patients Stroke 19 1988 604 607
18. M.M. Hoehn, and M.D. Yahr Parkinsonism: onset, progression and mortality Neurology 17 1967 427 442
19. L. Zecca, D. Tampellini, and M. Gerlach Substantia nigra neuromelanin: structure, synthesis, and behavior Mol Pathol 54 2001 414 418
20. K.M. Earle Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue J Neuropathol Exp Neurol 27 1968 1 14
21. E. Sofic, P. Riederer, and H. Heinsen Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brains J Neural Transm 744 1988 199 205
22. D.T. Dexter, F.R. Wells, and A.J. Lees Increased nigral iron content and alterations in other metal ions occurring in the brain in Parkinson's disease J Neurochem 52 1989 1830 1836 (Pubitemid 19140770)
23. P. Riederer, E. Sofic, and W.D. Rausch Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains J Neurochem 52 1989 515 520 (Pubitemid 19037617)
24. J. Galazka-Friedman, and A. Friedman Controversies about iron in parkinsonian and control substantia nigra Acta Neurobiol Exp 57 1997 217 225 (Pubitemid 27364552)